Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 5 (2008), Issue 7 (July)

1. Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy.
   Clin Cancer Res, 14(13): 4259-66. [Abstract] [Full-text]
2. Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial).
   Clin Cancer Res, 14(13): 4192-9. [Abstract] [Full-text]
3. Proapoptotic Bad and Bid protein expression predict survival in stages II and III colon cancers.
   Clin Cancer Res, 14(13): 4128-33. [Abstract] [Full-text]
4. Mechanisms by which E-selectin regulates diapedesis of colon cancer cells under flow conditions.
   Cancer Res, 68(13): 5167-76. [Abstract] [Full-text]
5. Serotonin regulates macrophage-mediated angiogenesis in a mouse model of colon cancer allografts.
   Cancer Res, 68(13): 5152-8. [Abstract] [Full-text]
6. Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating beta-catenin signaling.
   Cancer Res, 68(13): 5086-95. [Abstract] [Full-text]
7. Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity.
   J Natl Cancer Inst, 100(13): 950-61. [Abstract] [Full-text]
8. Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosa.
   Br J Cancer, 99(1): 136-42. [Abstract] [Full-text]
9. The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway.
   Dig Dis Sci, 53(8): 2195-203. [Abstract] [Full-text]
10. Serrated adenoma is a risk factor for subsequent adenomatous polyps.
    Dig Dis Sci, 53(8): 2204-7. [Abstract] [Full-text]
11. Immunohistochemical examination of anti-STn monoclonal antibodies LLU9B4, B72.3, and B35.2 for their potential use as tumor markers.
    Dig Dis Sci, 53(8): 2189-94. [Abstract] [Full-text]
12. Fibroblastic polyp of the colon and colonic perineurioma: 2 names for a single entity?
    Am J Surg Pathol, 32(7): 1088-94. [Abstract] [Full-text]
13. Multimedia article. Laparoscopic restorative proctocolectomy with small McBurney incision for ileal pouch construction without protective ileostomy.
    Dis Colon Rectum, 51(7): 1137-8. [Abstract] [Full-text]
14. An innovative technique for colorectal specimen retrieval: a new era of "natural orifice specimen extraction" (N.O.S.E).
    Dis Colon Rectum, 51(7): 1120-4. [Abstract] [Full-text]
15. A prospective evaluation of sexual function and quality of life after ileal pouch-anal anastomosis.
    Dis Colon Rectum, 51(7): 1032-5. [Abstract] [Full-text]
16. Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells.
    Oncogene, 27(29): 4024-33. [Abstract] [Full-text]
17. Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts.
    Cancer Lett, 267(1): 26-36. [Abstract] [Full-text]
18. Periostin is expressed in pericryptal fibroblasts and cancer-associated fibroblasts in the colon.
    J Histochem Cytochem, 56(8): 753-64. [Abstract] [Full-text]
19. P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.
    Oncogene, 27(30): 4161-71. [Abstract] [Full-text]
20. Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease.
    Clin Sci (Lond), 115(4): 107-27. [Abstract] [Full-text]
21. Hepatic ischemia-reperfusion increases vascular endothelial growth factor and cancer growth in rats.
    J Surg Res, 148(2): 158-63. [Abstract] [Full-text]
22. Phenotype and function of dendritic cells and T-lymphocyte polarization in the human colonic mucosa and adenocarcinoma.
    Eur J Surg Oncol, 34(8): 883-9. [Abstract] [Full-text]
23. Genetic and epigenetic changes in colon cancer.
    Exp Mol Pathol, 85(1): 64-7. [Abstract] [Full-text]
24. Gene-expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene-expression analyses: identification and validation of IFITM3 as a biomarker of early colon carcinogenesis.
    Cancer, 113(2): 266-75. [Abstract] [Full-text]
25. Defining a chromatin pattern that characterizes DNA-hypermethylated genes in colon cancer cells.
    Cancer Res, 68(14): 5753-9. [Abstract] [Full-text]
26. Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y, and p38 mitogen-activated protein kinase.
    Mol Cell Biol, 28(15): 4665-74. [Abstract] [Full-text]
27. Postoperative medical complications are the main cause of early death after emergency surgery for colonic cancer.
    Br J Surg, 95(8): 1012-9. [Abstract] [Full-text]
28. Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells.
    Mol Pharmacol, 74(2): 476-84. [Abstract] [Full-text]
29. Suppression of integrin alphaupsilonbeta6 by RNA interference in colon cancer cells inhibits extracellular matrix degradation through the MAPK pathway.
    Int J Cancer, 123(6): 1311-7. [Abstract] [Full-text]
30. DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3.
    Oncogene, 27(32): 4467-77. [Abstract] [Full-text]
31. Expression of galectin-3 in the tumor immune response in colon cancer.
    Lab Invest, 88(8): 896-906. [Abstract] [Full-text]
32. Quality of colon cancer outcomes in hospitals with a high percentage of Medicaid patients.
    J Am Coll Surg, 207(2): 197-204. [Abstract] [Full-text]
33. Design considerations in a sib-pair study of linkage for susceptibility loci in cancer.
    BMC Med Genet, 9: 64. [Abstract] [Full-text]
34. Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells.
    Br J Cancer, 99(3): 502-12. [Abstract] [Full-text]
35. Herbal isoprenols induce apoptosis in human colon cancer cells through transcriptional activation of PPARgamma.
    Cancer Invest, 26(7): 708-17. [Abstract] [Full-text]
36. Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism.
    Biochem Biophys Res Commun, 374(1): 111-6. [Abstract] [Full-text]
37. Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe.
    Oncogene, 27(33): 4544-56. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.